GPC3/CD3 bispecific antibody (Southern Medical University)

N/A

Report date: 2026/04/22 20:01:10

Base Information

Drug NameGPC3/CD3 bispecific antibody (Southern Medical University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-Glypican-3CD3 T-cell engagers
TargetsGlypican-3T cell surface glycoprotein CD3
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSouthern Medical University, China
China Registration ClassN/A

Develop Information

Active CompaniesSouthern Medical University, China
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A